Onyx Pharmaceuticals, Inc.
Bayanan rajista na hukuma
0masu bi
2013an kafa
Game da Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. was a pharmaceutical company headquartered in South San Francisco, California that developed and marketed cancer treatment medications. It was founded and incorporated with the California Secretary of State in February 1992 by venture capitalist Kevin J. Kinsella and Frank McCormick, Ph.D., FRS, D.Sc. (Hon.), a renowned British-American biochemist. McCormick served as the chief scientific officer until 1996, while Kinsella chaired the company's board of directors. On March 26, 1996, Onyx withdrew its corporate registration with the California Secretary of State and reincorporated in the state of Delaware in advance of successfully taking the company public on the NASDAQ exchange using National Market symbol ONXX on May 9, 1996. In 2009, the company acquired private biotechnology company Proteolix for US$276 million in cash plus additional milestone payments. In January 2012, the company was named "the top biotechnology takeover target in 2012" in an industry survey conducted by the ISI Group. Onyx president and CEO N. Anthony Coles had said that Onyx liked its prospects as an independent company and was focused on bringing new therapies to patients. However, by the end of August 2013, Amgen announced that it was acquiring Onyx in an agreed US$10.4 billion deal.
Source: Wikipedia
HedikwataCorporation Trust Center, 1209 Orange Street, 19801, Wilmington, US
An kafa2013
MatsayiMai aiki
Haƙƙoƙin ƙirƙira60 haƙƙoƙin ƙirƙira
METHODS OF TREATING MULTIPLE MYELOMA USING BCL-2 INHIBITOREP4558143A4 · 2026
Methods of treating multiple myelomaUS12636340B2 · 2026
Shiga don ganin duk haƙƙoƙin ƙirƙira 60
Duba cikakken fayil ɗin haƙƙoƙin ƙirƙira, tare da lambobin wallafa, kwanan wata da iyalai.
Shiga Ƙirƙiri asusu da imel ɗinkuKyauta ne
Idan kuka ci gaba, kuna yarda da Yarjejeniyar mai amfani, Manufar sirri da Manufar kukis na Heelky.
Bitoci
Babu bitoci tukuna. Ka yi aiki da Onyx Pharmaceuticals, Inc.? Kasance na farko da zai raba gogewarsa.
Bayanan doka
| Sunan doka | Onyx Pharmaceuticals, Inc. |
|---|---|
| LEI | 549300K47GO90N8J4853Duba a GLEIF ↗ |
| Adireshin da aka yi rajista | Corporation Trust Center, 1209 Orange Street, 19801, Wilmington, US |
| Matsayi | Mai aiki |
Tushe: GLEIF · an sabunta Oct. 16, 2026
Tuntuɓa & hanyoyin haɗi
Wuri
Corporation Trust Center, 1209 Orange Street, 19801, Wilmington, US
Wannan kamfaninka ne?
Yi da'awar wannan shafi kyauta don ƙara tambari, kayayyaki, hotuna da ayyuka, da amsa bitoci.
Yi da'awar wannan shafiShiga Heelky don haɗuwa, ɗaukar ma'aikata da haɓaka
Ƙirƙiri asusu kyauta don aika wa mutane saƙo, neman ayyuka da wallafa kwangiloli.
Shiga yanzu — kyauta ne